| --- | --- | |------------------------------------------|-------| | | | | | | | | | | | | | | | | Creating value by fulfilling our purpose | | | Advancing the World of Health ™ | | | August 5, 2021 | | Caution Concerning Forward-Looking Statements This presentation contains certain estimates and other forward-looking statements (as defined under Federal securities laws) regarding BD's future prospects and performance, including, but not limited to, future revenues, margins, earnings per share, leverage tar ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-4802 Becton, Dickinson and Company (Exact name of registrant as specified in its charter) New Jersey 22-0760120 (State or other j ...

Becton, Dickinson and Company (NYSE:BDX) Q2 2021 Earnings Conference Call May 6, 2021 8:00 AM ET Company Participants Kristen Stewart - Senior Vice President Strategy & Investor Relations Tom Polen - Chairman, Chief Executive Officer & President Dev Kurdikar - Worldwide President, Diabetes Care Chris Reidy - Executive Vice President, Chief Financial Officer & Chief Administrative Officer Simon Campion - President, Interventional Dave Hickey - President, Life Sciences Conference Call Participants Bob Hopk ...

| --- | --- | |------------------------------------------|-------| | | | | | | | | | | | | | | | | Creating value by fulfilling our purpose | | | Advancing the World of Health ™ | | | May 6, 2021 | | Caution Concerning Forward-Looking Statements This presentation contains certain estimates and other forward-looking statements (as defined under Federal securities laws) regarding BD's future prospects and performance, including, but not limited to, future revenues, earnings per share, leverage targets, capita ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-4802 Becton, Dickinson and Company (Exact name of registrant as specified in its charter) New Jersey 22-0760120 (State or other ...

Becton, Dickinson and Company (NYSE:BDX) Q1 2021 Results Conference Call February 4, 2021 8:00 AM ET Company Participants Kristen Stewart - Senior Vice President Strategy and Investor Relations Thomas Polen - President and Chief Executive Officer Christopher Reidy - Chief Financial Officer and Chief Administrative Officer Dave Hickey - President of Life Sciences Simon Campion - President of Interventional Conference Call Participants David Lewis - Morgan Stanley Robert Marcus - JPMorgan Chase & Co Vijay Ku ...

| --- | --- | |---------------------------------|-------| | | | | | | | | | | | | | | | | | | | Q1 FY2021 | | | Overview & Financial Supplement | | | February 4, 2021 | | | 1 | | Disclaimer 2 Caution Concerning Forward-Looking Statements This presentation contains certain estimates and other forward-looking statements (as defined under Federal securities laws) regarding BD's future prospects and performance, including, but not limited to, future revenues, margins, and earnings per share, leverage targets, c ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-4802 Becton, Dickinson and Company (Exact name of registrant as specified in its charter) New Jersey 22-0760120 (State or oth ...

Driving Value Creation through Fulfilling our Purpose Tom Polen CEO and President 39th Annual J.P. Morgan Conference January 12, 2021 Caution Concerning Forward-Looking Statements 2 This presentation contains certain estimates and other forward-looking statements (as defined under Federal securities laws) regarding BD's future prospects and performance, including, but not limited to, future revenues, margins, and earnings per share, leverage targets, capital deployment and total return targets. All such sta ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NUMBER: 001-4802 BECTON, DICKINSON AND COMPANY (Exact name of registrant as specified in its charter) New Jersey 22-0760120 (Sta ...